Introduction: Targeting Angiogenesis in Cancer Therapy

Herbert I. Hurwitz
The Oncologist 2004; 9(Supplement 1 ): 1; doi:10.1634/theoncologist.9-suppl_1-1
[Full Text] [PDF]  

Vascular Endothelial Growth Factor as a Target for Anticancer Therapy

Napoleone Ferrara
The Oncologist 2004; 9(Supplement 1 ): 2-10; doi:10.1634/theoncologist.9-suppl_1-2
[Abstract] [Full Text] [PDF]  

Targeted Therapy of Colorectal Cancer: Clinical Experience with Bevacizumab

Nishan H. Fernando, Herbert I. Hurwitz
The Oncologist 2004; 9(Supplement 1 ): 11-18; doi:10.1634/theoncologist.9-suppl_1-11
[Abstract] [Full Text] [PDF]  

Non-Small Cell Lung Cancer and Antiangiogenic Therapy: What Can Be Expected of Bevacizumab?

Roy S. Herbst, Alan B. Sandler
The Oncologist 2004; 9(Supplement 1 ): 19-26; doi:10.1634/theoncologist.9-suppl_1-19
[Abstract] [Full Text] [PDF]  

Expanding the Clinical Development of Bevacizumab

Helen X. Chen
The Oncologist 2004; 9(Supplement 1 ): 27-35; doi:10.1634/theoncologist.9-suppl_1-27
[Abstract] [Full Text] [PDF]  

Maximizing the Potential of Bevacizumab in Cancer Treatment

Emily Bergsland, Maura N. Dickler
The Oncologist 2004; 9(Supplement 1 ): 36-42; doi:10.1634/theoncologist.9-suppl_1-36
[Abstract] [Full Text] [PDF]  

Bevacizumab in the Treatment of Breast Cancer: Rationale and Current Data

Hope S. Rugo
The Oncologist 2004; 9(Supplement 1 ): 43-49; doi:10.1634/theoncologist.9-suppl_1-43
[Abstract] [Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.